Gamco Investors INC. ET AL Has $8.18 Million Stock Holdings in Option Care Health, Inc. $OPCH

Gamco Investors INC. ET AL decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 17.6% in the first quarter, Holdings Channel reports. The firm owned 303,927 shares of the company’s stock after selling 65,075 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Option Care Health were worth $8,182,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. V Square Quantitative Management LLC acquired a new stake in shares of Option Care Health during the fourth quarter worth approximately $25,000. McIlrath & Eck LLC bought a new position in shares of Option Care Health in the 2nd quarter worth $37,000. Advisory Services Network LLC bought a new position in Option Care Health during the 3rd quarter worth approximately $35,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Option Care Health in the 3rd quarter valued at $38,000. Finally, Employees Retirement System of Texas bought a new stake in shares of Option Care Health in the fourth quarter worth about $45,000. Institutional investors own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

OPCH has been the topic of a number of research analyst reports. Zacks Research upgraded shares of Option Care Health from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Weiss Ratings lowered shares of Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $26.00 price objective on shares of Option Care Health in a research report on Friday, May 1st. Barrington Research reduced their target price on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Finally, The Goldman Sachs Group initiated coverage on Option Care Health in a research note on Monday, June 8th. They issued a “neutral” rating and a $22.00 price target for the company. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $30.08.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the firm’s stock in a transaction on Monday, May 4th. The stock was purchased at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the acquisition, the director owned 450,000 shares in the company, valued at approximately $9,634,500. The trade was a 8.86% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy P. Sullivan purchased 24,154 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was acquired at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the purchase, the director owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. This trade represents a 49.06% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 73,264 shares of company stock valued at $1,548,316 in the last three months. Insiders own 1.70% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH opened at $21.66 on Monday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64. The firm has a market cap of $3.40 billion, a price-to-earnings ratio of 16.79, a PEG ratio of 1.20 and a beta of 0.65. Option Care Health, Inc. has a 52-week low of $18.01 and a 52-week high of $36.80. The business’s fifty day moving average is $21.32 and its 200-day moving average is $27.09.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter last year, the business posted $0.40 EPS. Option Care Health’s revenue for the quarter was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities analysts anticipate that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.